| Primary |
| Adult T-cell Lymphoma/leukaemia |
28.6% |
| Lymphoma |
14.0% |
| Breast Cancer |
11.6% |
| Hodgkin's Disease |
7.3% |
| Non-hodgkin's Lymphoma |
6.7% |
| Diffuse Large B-cell Lymphoma |
4.3% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Angioimmunoblastic T-cell Lymphoma |
2.4% |
| Peripheral T-cell Lymphoma Unspecified |
2.4% |
| Extranodal Nk/t-cell Lymphoma, Nasal Type |
2.1% |
| Hepatic Neoplasm Malignant |
2.1% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
1.8% |
| Antifungal Prophylaxis |
1.8% |
| B-cell Lymphoma |
1.8% |
| B-cell Small Lymphocytic Lymphoma |
1.8% |
| Constipation |
1.8% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
1.8% |
| Mycosis Fungoides |
1.8% |
| Rhabdomyosarcoma |
1.8% |
| Pneumonia |
1.5% |
|
| Neoplasm Malignant |
13.2% |
| Pneumonia |
10.3% |
| Second Primary Malignancy |
10.3% |
| Febrile Neutropenia |
7.4% |
| Allergic Cystitis |
5.9% |
| Frontotemporal Dementia |
5.9% |
| Appendicitis |
4.4% |
| Liver Disorder |
4.4% |
| Pancreatitis Acute |
4.4% |
| Tumour Lysis Syndrome |
4.4% |
| Bone Marrow Failure |
2.9% |
| Cardiac Failure |
2.9% |
| Cardiac Failure Acute |
2.9% |
| Clostridium Difficile Colitis |
2.9% |
| Death |
2.9% |
| Hepatitis B |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Pneumonitis |
2.9% |
| Pulmonary Embolism |
2.9% |
| Ureteric Cancer |
2.9% |
|
| Secondary |
| Adult T-cell Lymphoma/leukaemia |
31.0% |
| Drug Use For Unknown Indication |
9.1% |
| Lymphoma |
7.5% |
| Prophylaxis |
5.1% |
| Product Used For Unknown Indication |
4.9% |
| Non-hodgkin's Lymphoma |
4.8% |
| Antifungal Prophylaxis |
4.3% |
| Constipation |
4.2% |
| Pneumonia |
3.7% |
| B-cell Lymphoma |
3.3% |
| Breast Cancer |
3.1% |
| Diffuse Large B-cell Lymphoma |
2.7% |
| Hypertension |
2.7% |
| Histiocytosis Haematophagic |
2.2% |
| Angioimmunoblastic T-cell Lymphoma |
2.0% |
| Ewing's Sarcoma |
2.0% |
| Hyperlipidaemia |
2.0% |
| Multiple Myeloma |
1.9% |
| Proctitis |
1.8% |
| Stomatitis |
1.8% |
|
| Pneumonia |
18.9% |
| White Blood Cell Count Decreased |
10.4% |
| Thrombocytopenia |
9.4% |
| Multi-organ Failure |
6.6% |
| Febrile Neutropenia |
5.7% |
| Myelodysplastic Syndrome |
5.7% |
| Sweat Gland Tumour |
5.7% |
| Stomatitis |
4.7% |
| Vomiting |
4.7% |
| Alveolitis Allergic |
3.8% |
| Death |
3.8% |
| Liver Disorder |
2.8% |
| Olfactory Nerve Disorder |
2.8% |
| Second Primary Malignancy |
2.8% |
| Sepsis |
2.8% |
| Chronic Eosinophilic Leukaemia |
1.9% |
| Gastric Perforation |
1.9% |
| Gastrointestinal Haemorrhage |
1.9% |
| Gastrointestinal Ulcer Haemorrhage |
1.9% |
| Grand Mal Convulsion |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.4% |
| Neoplasm Malignant |
17.0% |
| Lymphoma |
8.5% |
| Multiple Myeloma |
5.8% |
| Acute Lymphocytic Leukaemia |
5.7% |
| Diffuse Large B-cell Lymphoma |
4.9% |
| Adult T-cell Lymphoma/leukaemia |
4.1% |
| Metastases To Bone |
4.1% |
| Breast Cancer |
3.7% |
| Prophylaxis |
3.5% |
| Chemotherapy |
2.9% |
| Mantle Cell Lymphoma |
2.6% |
| Hypertension |
2.5% |
| Non-hodgkin's Lymphoma |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Metastases To Liver |
2.1% |
| Gastric Ulcer |
2.0% |
| Pyrexia |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Malignant Neoplasm Of Renal Pelvis |
1.5% |
|
| Pyrexia |
8.2% |
| Interstitial Lung Disease |
7.1% |
| Myalgia |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Somnolence |
5.9% |
| Treatment Related Secondary Malignancy |
5.9% |
| Aids Encephalopathy |
4.7% |
| Cerebral Infarction |
4.7% |
| Gamma-glutamyltransferase Increased |
4.7% |
| Hepatic Function Abnormal |
4.7% |
| Organising Pneumonia |
4.7% |
| Thrombocytopenia |
4.7% |
| Tooth Extraction |
4.7% |
| Vomiting |
4.7% |
| Hepatitis Fulminant |
3.5% |
| Nerve Injury |
3.5% |
| Pleural Effusion |
3.5% |
| Pneumocystis Jiroveci Pneumonia |
3.5% |
| Protein Urine Present |
3.5% |
| Pulmonary Hypertension |
3.5% |
|
